Bishal Gyawali, Associate Professor at Queen’s University, shared a post on LinkedIn:
“I have two passions- cancer policy and philosophy/spirituality.
Very rarely do I get to combine these two in the same academic article.
Thankful to Nature Reviews Clinical Oncology for publishing our comment on ATOMIC trial, where I explain the treatment of stage 3 colon cancer using the analogy of a Zen Koan.”
Title: Did ATOMIC really improve on the standard of care for mismatch repair-deficient colon cancer?
Authors: Javier-David Benítez-Fuentes, Deme Karikios, Bishal Gyawali
Other articles featuring Bishal Gyawali on OncoDaily.
